Who Paid My Doc
Robert Buynak
Internal Medicine Valparaiso, IN Medical Doctor
NPI 1508977984 CMS profile 340544
454 College Ave, Valparaiso, IN 46383
General payments
$15,038
Research payments
$6,159
Ownership & investment interest
$0
Research they led as principal investigator
$24,139,881
Through program year 2025, Robert Buynak of Valparaiso, IN is reported in the CMS Open Payments database as having received $15,038 across 106 general payments and $6,159 in research payments paid to them. Separately, studies naming them as principal investigator received $24,139,881 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 97th percentile of Internal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
9 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $2,543 | 14 | |
| 2024 | General | $2,805 | 27 | |
| 2023 | General | $2,547 | 21 | |
| 2023 | Research | $907 | 2 | |
| 2022 | General | $1,516 | 9 | |
| 2022 | Research | $3,105 | 10 | |
| 2020 | Research | $1,489 | 13 | |
| 2019 | General | $5,627 | 35 | |
| 2019 | Research | $659 | 10 |
Beside peers
- Robert Buynak
- Internal Medicine median
- Middle half of Internal Medicine
- National median
In program year 2025, general payments to Robert Buynak were reported at $2,543. Among 52,115 Internal Medicine profiles paid that year, the median was $156 and the middle half received between $47 and $551.
Show as a table
| Year | Robert Buynak | Internal Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $5,627 | $159 | $48–$570 | $163 |
| 2020 | $0 | $119 | $33–$402 | $114 |
| 2021 | $0 | $135 | $37–$521 | $132 |
| 2022 | $1,516 | $141 | $42–$496 | $149 |
| 2023 | $2,547 | $149 | $45–$519 | $160 |
| 2024 | $2,805 | $154 | $47–$537 | $164 |
| 2025 | $2,543 | $156 | $47–$551 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
141 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Internal Medicine in Indiana
Abhinav Singh
Internal Medicine · Greenwood, IN
Girish Kunapareddy
Internal Medicine · Terre Haute, IN
Raj Vuppalanchi
Internal Medicine · Indianapolis, IN
Joseph Arulandu
Internal Medicine · La Porte, IN
Napoleon Maminta
Internal Medicine · Indianapolis, IN
Jennifer Paisley
Internal Medicine · Lawrenceburg, IN
Related records
Internal Medicine in Indiana
Practitioners in the same specialty and state, ranked by reported value.
All Internal Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Indiana
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.